key: cord-0037682-yy7at6dg authors: Di Silvestre, Dario; Brunetti, Pietro; Mauri, Pier Luigi title: Processing of Mass Spectrometry Data in Clinical Applications date: 2012-12-27 journal: Bioinformatics of Human Proteomics DOI: 10.1007/978-94-007-5811-7_9 sha: c9e2c3e3615e8c0e306651d8eb22b6f888353027 doc_id: 37682 cord_uid: yy7at6dg Mass spectrometry-based proteomics has become the leading approach for analyzing complex biological samples at a large-scale level. Its importance for clinical applications is more and more increasing, thanks to the development of high-performing instruments which allow the discovery of disease-specific biomarkers and an automated and rapid protein profiling of the analyzed samples. In this scenario, the large-scale production of proteomic data has driven the development of specific bioinformatic tools to assist researchers during the discovery processes. Here, we discuss the main methods, algorithms, and procedures to identify and use biomarkers for clinical and research purposes. In particular, we have been focused on quantitative approaches, the identification of proteotypic peptides, and the classification of samples, using proteomic data. Finally, this chapter is concluded by reporting the integration of experimental data with network datasets, as valuable instrument for identifying alterations that underline the emergence of specific phenotypes. Based on our experience, we show some examples taking into consideration experimental data obtained by multidimensional protein identification technology (MudPIT) approach. The increasing availability of fully sequenced genomes is making the high-throughput proteomics research more and more possible. Developments in fractionation approaches coupled to advances in liquid chromatography (LC), mass spectrometry (MS), and bioinformatic tools have made proteomic approaches mature to analyze complex proteomes, such as Homo sapiens . In fact, although proteome complexity prevents the quantitative pro fi ling of all proteins expressed in a cell or tissue at a given time, higher sensitivity, accuracy, and resolution of new MS instruments allow routine analysis, reaching limit of detection of attomole and dynamic range of 1e 6 (Yates et al. 2009 ) . High-throughput proteomics approaches allow to identify and quantify hundreds of proteins per sample, giving a snapshot of cells or tissues associated with different phenotypes. This wealth of data has driven strategies of investigation based on systems biology approaches, allowing insight into disease, taking into consideration functional relationship among proteins (Gstaiger and Aebersold 2009 ) . In addition, highly speci fi c biomarkers represent also key features for improving methods of diagnosis and prognosis or for monitoring disease progression under appropriate therapeutic approaches (Palmblad et al. 2009 ; Simpson et al. 2009 ) . In this context, MS has been introduced as a tool for enhancing the current clinical application practices and potentially for targeting the development of personalized medicine (Brambilla et al. 2012 ) . The ultimate success of MS-based proteomics analysis, both for research and for clinical applications, may be affected by several aspects. Like sample preparation, pre-fractionation methodologies, or instrument setup, data processing procedures represent an important step for obtaining good results and their correct interpretation. Evaluation of thousands of data by hand/eye is time consuming and subjected to biases and missed results. Therefore, to assist researchers during the different stages of analysis and to improve understanding of biological systems, an increasing number of tools and procedures are continually developing, giving rise to a speci fi c bioinformatics area for proteomic applications (Di . In this chapter, we make an overview of the computational trends for processing proteomic data obtained by MS-based proteomics approaches. Based on our experience, we focused primarily on strategies related to multidimensional protein identi fi cation technology (MudPIT) approach (Mauri and Scigelova 2009 ) , (Fig. 9 .1 ). In particular, we have explored methods, algorithms, and procedures used for biomarker discovery, by means of label and label-free methods. In this context, we then introduce the main advances of the targeted proteomics (Lange et al. 2008 ) by investigating the bioinformatics aspects concerning the identi fi cation of proteotypic peptides (Craig et al. 2005 ; Kuster et al. 2005 ) . In the second part of the chapter, we discuss recent advances regarding clinical proteomics application for discriminating sample, such as diseased and healthy. Finally, since most known mechanisms leading to disease involve multiple molecules, we conclude with a discussion of the integration of proteomic data with network datasets, as a promising framework for identifying subnetwork that underlines the emergence of speci fi c phenotypes. Fig. 9 .1 Multidimensional protein identi fi cation technology represents a fully automated technology that simultaneously allows separation of digested peptides, their sequencing, and identi fi cation of the corresponding proteins. Peptides are separated by means of strong ion exchange ( SCX ), using steps of increasing salt concentration, followed by C18 reverse phase ( RP ) chromatography, using an acetonitrile gradient. Finally, eluted peptides are directly analyzed by MS and raw spectra processed by speci fi c algorithms and bioinformatics tools (see Supplemental Information Table 1 ). In this way, MudPIT permits simultaneous identi fi cation of hundreds, or even thousands, of proteins without limits related to pI, MW, or hydrophobicity. This huge amount of data represents a rich source of information, and their content may be exploited for discovery and classi fi cation approaches Quanti fi cation of proteomic differences between samples at different biological condition, such as healthy and diseased, is a helpful strategy for providing important biological and physiological information concerning disease state (Simpson et al. 2009 ; Abu-Asab et al. 2011 ) . For this purpose, MS-based approaches are applied for identifying proteins changing their abundance by comparing two or more samples. They consist of different strategies basically belonging to two categories which rely on stable isotope-labeling and label-free methodologies (Domon and Aebersold 2010 ) . As for labeling approaches, isotopes are introduced in the peptides to create a speci fi c mass tag recognized by MS (Kline and Sussman 2010 ) . Accordingly, quanti fi cation is achieved by measuring the ratio of the signal intensities between the unlabeled peptide and its identical counterpart enriched with isotopes (further details on stable isotope-labeling methods are reported in Supplemental Information ). Absolute measurements of protein concentration may be achieved with spiked synthetic peptides, as in QconCAT (Mirzaei et al. 2008 ) , AQUA (Gerber et al. 2003 ) , SISCAPA (Anderson et al. 2004 ) , VICAT (Lu et al. 2007 ) , and PC-IDMS ( Barnidge et al. 2004 ) . Quanti fi cation is obtained by adding into the sample a known amount of an isotopically labeled peptide. In this way, the level of the endogenous form of peptide can be calculated. Of course, the identity of the peptide must be known prior to analysis by MS. Sometimes, if the m/z ratio of the spiked standard is the same of other peptides, it may lead to an inaccurate quanti fi cation. In this case, the ambiguity of the results may be minimized combining these approaches with the selected reaction monitoring (SRM) (Lange et al. 2008 ) . Although the approaches by labeling, with or without internal standard, allow a highly reproducible and accurate quanti fi cation of proteins, most of them have potential limitations, such as the complexity of sample preparation, the requirement of a large amount of time, the requirement of speci fi c bioinformatics tools, and the high cost. As opposite, a simpler alternative concerns label-free approaches (Zhu et al. 2010 ) . They are basically based on counting of peptides identi fi ed by means of tandem mass spectrometry (MS/MS) or by evaluating the signal intensity of peptides. Spectral sampling is directly proportional to the relative abundance of the protein in the mixture and therefore represents an attractive methodology, thanks to their intrinsic simplicity, throughput, and low cost. For these reasons, researchers are increasingly turning to label-free shotgun proteomics approaches (Zhu et al. 2010 ) . Even if they are less accurate, due to the systematic and nonsystematic variations between the experiments, they represent an attractive alternative for their high-throughput setting that also allows the comparison of an unlimited number of experiments with less time consumed. However, efforts should be made to improve experimentally reproducibility and so consequently the reliability of differentially expressed proteins. A variety of label-free methodologies for semiquantitative evaluation of proteins have been described in literature by reporting a direct relationship between the protein abundance and the sampling parameters associated with identi fi ed proteins and peptides (Florens et al. 2002 ; Gao et al. 2003 ; Wang et al. 2003 ; Bridges et al. 2007 ) . One of the most diffused approaches uses the spectral count (SpC) value (Liu et al. 2004 ) and is based on the empirical observation that more is the quantity of a protein in a sample and more tandem MS spectra may be collected for its peptides. In this context, the normalized spectral abundance factor (NSAF), or its natural log transformation, has been used for the quantitative evaluation with t-test analysis (Zybailov et al. 2006 ) . Other authors have used the protein abundance index (PAI or emPAI) that is calculated by dividing, for each protein, the number of observed peptides by the number of all possible detectable tryptic peptides (Ishihama et al. 2005 ) , while Zhang and colleagues processed SpC values by means of the statistical G-test as previously described (Zhang et al. 2006 ) . The need to automate the procedure for identifying biomarkers has driven many research groups to develop algorithms and in-house software for identi fi cation, visualization, and quanti fi cation of mass spectrometry data. Census (Park et al. 2008 ) and MSQuant (Mortensen et al. 2010 ) software allows protein quanti fi cation by processing MS and MS/MS spectra and they are compatible with label and label-free analysis as well as with high-and low-resolution MS data. In addition, Protein-Quant Suite (Mann et al. 2008 ) and ProtQuant ) software are attractive because they allow processing of data in different fi le formats, therefore collected by different types of mass spectrometers. This aspect focuses attention on the standardization of mass spectrometric data for their sharing and dissemination. In fact, over the years, MS instrument manufacturers have developed proprietary data formats, making it dif fi cult. However, to address this limitation, several tools, such as Trans-Proteomic Pipeline , allow the conversion of MS data in standard format, like mzData, mzXML, or mzML (Orchard et al. 2010 ) . The list of computational tools developed for label-free quantitative analysis, by using LC-MS data, is very long. In addition to Corra ) and APEX (Braisted et al. 2008 ) tools, PatternLab (Carvalho et al. 2008 ) allows different data normalization strategies, such as Total Signal, log preprocessing (by ln), Z normalization, Maximum Signal, and Row Sigma, for implementing ACFold and nSVM (natural support vector machine) methods to identify protein expression differences. Based on our experience on proteomic analysis based on MudPIT approach, we developed a simple tool, called MAProMA (Multidimensional Algorithm Protein Map) . It is based on a label-free quantitative approach based on processing of score/SpC values, by means of Dave and DCI algorithms (see Supplemental Information ). Its effectiveness has been demonstrated in various studies Regonesi et al. 2006 ; ) . In addition, MAProMa allows the comparison of up to 125 protein lists and data visualization in a format more comprehensible to biologists ( Fig. 9 .2 ). A limitation of shotgun proteomics is due to potential inference problem that may affect protein quanti fi cation (Nesvizhskii and Aebersold 2005 ) . In addition, limit of detection "may" exclude the identi fi cation of biologically relevant molecules. For identifying, validating, and transferring them to the routine clinical analysis, targeted proteomics or "selected reaction monitoring" (SRM) has been recently developed (Lange et al. 2008 ; Shipkova et al. 2008 ; Yang and Lazar 2009 ) . The robustness and the simplicity of its data analysis are ideally suited for detecting and quantifying with high con fi dence up to 100 proteins per sample. For this purpose, mass spectrometers and bioinformatics tools are set to explore a de fi ned number of proteins of interest, following, for each one, a set of representative peptides with a known m/z value. They are fragmented, and the monitoring of a speci fi c daughter fragments allow a combination precursor-product, called "transition," that is highly speci fi c for each amino acid sequence. These peptides, called proteotypic peptides, describe something typical of a protein. Initially, they were de fi ned as the most observed peptides by the current MS-based proteomics approaches (Craig et al. 2005 ) . Then , other authors added the uniqueness condition for a protein (Kuster et al. 2005 ) , while more recently an empirical de fi nition that de fi nes proteotypic peptide as a peptide observed in more than 50% of all identi fi cations of the corresponding parent protein was appended (Mallick et al. 2007 ) . In other words, these peptides have to be previously identi fi ed, with a known MS/MS fragmentation pattern and speci fi c for each targeted protein. The identi fi cation of proteotypic peptides useful for targeted proteomics is based on three different methods: 1. By experimental MS/MS data 2. By searching in speci fi c databases 3. By using predictive strategies The fi rst one is based on the selection of peptides by using the adopted de fi nitions. It allows also the investigation of organisms with proteotypic peptide data not stored inside speci fi c data repositories. In this context, several databases have been developed. In particular: Global Proteome Machine Database (Craig et al. • 2004 ) allows users to quickly compare their experimental results with the results previously observed by other scientists. For each dataset, it is possible to view observed spectra for the design of SRM experiments. Query of data may be performed by protein name or Ensembl identi fi er with the possibility to restrict search to a speci fi c data source, such as eukaryotes, prokaryotes, virus, or precise organism. In addition, further fi lters may be set by keywords comprising organs, cell location, protein function, or PubMed id. (maps) . It automatically plots in a virtual 2D map the Mw vs. pI for each protein identi fi ed, assigning it a color/shape according to a range of a sampling statistics (score or SpC) derived by SEQUEST data handling. This representation permits to have a rapid visual of the proteins that change comparing two or more conditions. In addition, using DAve and DCI algorithms, MAProMa reports a histogram that shows the differentially expressed proteins, their identi fi er, and their DAve value GPM project is linked to X! Software series and, of course, with X! P3, the algorithm that makes possible the use of their spectra for pro fi ling proteotypic peptide. PeptideAtlas (Desiere • 2006 ) is a publicly accessible source of peptides experimentally identi fi ed by tandem mass spectrometry. Raw data, search results, and full builds may be also downloaded. User may browse data, selecting different sources, and few of these need the permission to access. Protein may be searched by different protein identi fi ers, such as Ensembl and IPI. In addition to general information like GO terms, orthologs, or description, a graphical description indicates the unique peptides found and their occurrence. For each one, it is possible to reach information, like spectra, modi fi cation, or genome mapping. PeptideAtlas is linked to Trans-Proteomic Pipeline ) that is used for processing data passed to PeptideAtlas and SBEAMS (Marzolf et al. 2006 ) . In particular, data are processed for deriving the probability of a correct identi fi cation and therefore for insuring a high-quality database. Other databases, designed for data warehousing, store MS/MS spectra collected from proteomics experiments. Even if they are not useful to fi nd proteotypic peptides, they may be used in the comparison with own experimental data. In particular: PRIDE (Martens et al. • 2005 ) stores experiments, identi fi ed proteins and peptides, unique peptides, and spectra. In addition to protein (name or various identi fi ers) and PRIDE experiment identi fi er, it is possible to browse PRIDE by species, tissue, cell type, GO terms, and disease. Proteome Commons (Hill et al. • 2010 ) is a public proteomics database linked to the Tranche (Falkner and Andrews 2007 ) , a powerful open-source web application designed to store and exchange data. A public access to free, open-source proteomics tools, articles, data, and annotations is provided. Proteomexchange (Hermjakob and Apweiler • 2006 ) is a work package for encouraging the data exchange and dissemination. Its consortium has been set up to provide a single point of submission of MS data concerning to the main existing proteomics repositories (at the moment PRIDE, PeptideAtlas, and Tranche). Experimental data stored in the described repositories represent a wealthy source of information, useful for bioinformaticians which attempt to design algorithms for predicting peptides most observable using MS. For this purpose, the STEPP software contains an implementation of a trained support vector machine (SVM) (Cristianini and Shawe-Taylor 2000 ; Vapnik 1999 ) that uses a simple descriptor space, based on 35 properties of amino acid, to compute a score representing how proteotypic a peptide is by LC-MS (Webb-Robertson 2009 ) . Similarly to STEPP, a predictor was developed, called Peptide Sieve (Mallick et al. 2007 ) , by studying physicochemical properties of more than 600,000 peptides identi fi ed by four different proteomic platforms. This predictor has the ability to accurately identify proteotypic peptides from any protein sequence and offer starting points for generating a physical model describing the factors that govern elements of proteomic work fl ows such as digestion, chromatography, ionization, and fragmentation. Other authors, like Tang et al., used neural networks (Riedmiller and Braun 1993 ) to develop the DetectabilityPredictor software that uses 175 amino acid properties (Tang et al. 2006 ) . In the same way, arti fi cial neural networks were used to predict peptides potentially observable for a given set of experimental, instrumental, and analytical conditions concerning multidimensional protein identi fi cation technology datasets (Sanders et al. 2007 ) . Finally, random forest (Breiman 2001 ) was used to develop enhanced signature peptide (ESP) predictor. It was speci fi cally designed for facilitating the development of targeted MS-based assays for biomarker veri fi cation or any application where protein levels need to be measured (Fusaro et al. 2009 ) . Clinical proteomics aims to use relevant data for improving disease diagnosis or for monitoring its progression (Palmblad et al. 2009 ; Brambilla et al. 2012 ) . In this context, biomarkers represent a key aspect to develop methods for classifying samples according to their phenotypes (e.g., healthy-diseased, early-late stage). In addition, to address the biological questions, technologies for high-throughput proteomics allow long lists of spectra, sequenced peptides, and parent proteins that represent a wealthy source of data for identifying predictive biomarkers. For these purposes, most studies have used spectra, generated by MALDI and SELDI technology, in combination with a wide variety of prediction algorithms. On the contrary, fewer cases have taken into consideration data obtained by LC-MS analysis (see Supplemental Information Table 2 ). However, results of LC-MS analysis (or by MudPIT) are formatted in an m × n matrix, with a structure very reminiscent of the output of microarray genomics experiments ( Fig. 9.3 ) . Hence, the software packages and the tools useful for analyzing genomics data may easily be used for proteomics (Ressom et al. 2008 ; Dakna et al. 2009 ) . Even if some properties of proteomic datasets are related to the analytical technology used to generate them, procedures for sample classi fi cation basically consist of four steps, such as data preprocessing, feature selection, classi fi cation, and cross-validation (Ressom et al. 2008 ; Dakna et al. 2009 ; Sampson et al. 2011 ; Barla et al. 2008 ) . The fi rst one aims to achieve reproducible results by minimizing errors due to the experimental-designed methodology. Mass spectral pro fi les may be in fl uenced by several factors, such as baseline effects, shifts in mass-to-charge ratio, alignment problem, or differences in signal intensities that may be corrected by speci fi c computational procedures (Yu et al. 2006 ; Arneberg et al. 2007 ; Pluskal et al. 2010 ) . In the same way, variation of sampling parameters associated with sequenced protein, such as spectral count or score, is adjusted using related strategies of data normalization (e.g., Total Signal, log preprocessing (by ln), Z normalization, Maximum Signal, or Row Sigma) (Carvalho et al. 2008 ) . Typically, MudPIT analysis generates a number of variables usually bigger than the number of analyzed samples (f >> s). This complexity represents a key problem of computational proteomics, and most classi fi cation methods require the reducing of the dimensionality prior to classi fi cation. It is obtained by Fig. 9. 3 Data matrix is obtained aligning features identi fi ed by analyzing sample by MudPIT approach. In this context, MAProMa software allows a rapid alignment of up to 125 protein lists. Rows in data matrix represent features (e.g., proteins, peptides, or m / z values) while columns indicate samples. Each cell of data matrix is represented by a value corresponding to parameter associated with features. In particular, spectral count, Xcorrelation (Xcorr), and signal intensity are used for protein, peptides, and m / z mass features, respectively discarding the irrelevant variables for obtaining a combination of features (f << s), highly correlated and with a more informative lower dimensional space that maximizes the quality of the hypothesis learned from these features (Guyon et al. 2006 ) . Feature selection procedures may be classi fi ed in three different approaches based on different processes to rank features: fi lter, wrapper, and embedded (Levner 2005 ) . A number of techniques have been used for the analysis of proteomic data, and these include methods such as support vector machines (SVM) and arti fi cial neural networks (ANN) as well as approaches like partial least squares (PLS), principal component regression (PCR), and principal component analysis (PCA). A good overview of statistical and machine learning-based feature selection and pattern classi fi cation algorithms is reported by Ressom and colleagues (Ressom et al. 2008 ) . Of course, different combinations of them show different sensitivity to noisy data and outliers as well as different susceptibility to the over-fi tting problem (Sampson et al. 2011 ) . A limitation of many machine learning-based classi fi cation algorithms is that they are not based on a probabilistic model; therefore, there is no con fi dence associated with the predictions of new datasets. Inadequate performance could be attributed to different reasons (e.g., insuf fi cient or redundant features, inappropriate model classi fi er, few or too many model parameters, under-or overtraining, and code error, as well as presence of highly nonlinear relationships, noise, and systematic bias). Thus, with the purpose of testing the adequacy/inadequacy of a classi fi er, after learning is completed, its performances are evaluated through validation set, previously unseen. For this purpose, various methods, such as k -fold cross-validation, bootstrapping, and holdout methods, have been used (Ressom et al. 2008 ) . The most common performance measures to evaluate the performances of classi fi ers are a confusion matrix and a receiver operating characteristic (ROC) curve. The fi rst one shows information about actual and predicted classi fi cations of a classi fi er and assesses its performances using standard indices, such as sensitivity, speci fi city, PPV, NPV, and accuracy values (see Supplemental Information ). On the other hand, ROC is a plot of the sensitivity of a classi fi er against 1-speci fi city for multiple decision thresholds. Proteomics is a holistic science that refers to the investigation of the entire systems. Before the advent of -omics technologies, reductionism has dominated the biological research for over a century by investigating individual cellular components. Despite its enormous success, it is more and more evident that most molecular functions occur from a concerted action of multiple molecules, and their investigation implies the examination of an ensemble of elements (Barabási and Oltvai 2004 ) . In fact, biomolecular interactions play a role in the majority of cellular processes that are regulated connecting numerous constituents, such as DNA, RNA, proteins, and small molecules. Data abstraction in pathways or networks is the natural result of the desire to rationalize knowledge of complex systems. More recently, their use has changed from purely illustrative to an analytic purpose. In fact, even if it is purely virtual and not related to any intrinsic structure in the cell or organism, understanding how, where, and when single components interact is fundamental to facilitate the investigation of experimental data by taking into consideration the functional relationship among molecules. A major challenge for biologists and bioinformaticians is to gain tools, procedures, and skills for integrating data into accurate models that can be used to generate hypotheses for testing. This objective is partially the result of the con fl uence in systems biology of advances in computer science and -omics technologies. In this context, systems biology approaches have evolved in different strategies basically belonging to two categories, such as computational systems biology, which uses modeling and simulation tools (Barrett et al. 2006 ; , and data-derived systems biology, which relies on "-omics" datasets (Rho et al. 2008 ; Li et al. 2009 ; Jianu et al. 2010 ; P fl ieger et al. 2011 ) . For deciphering mechanisms of complex and multifactorial diseases, such as those concerning heart failure, recent studies have coupled proteomic and systems biology approaches (Wheelock et al. 2009 ; Isserlin et al. 2010 ; Arrell et al. 2011 ) . From a standpoint of the data visualization, the possibility to map protein expression onto pathway or network reveals how they are modulated under different conditions, such as healthy and disease states (Gstaiger and Aebersold 2009 ; Sodek et al. 2008 ) . About that, an unbiased procedure to identify subnetworks which change consistently between different states involves three key steps: 1. The execution of high-throughput proteomic experiments 2. The identi fi cation of candidate biomarkers by label or label-free methods 3. The integration of data into network model to identify clusters of proteins with under, over, and normal expression In addition, subnetwork selected using experimental data may be analyzed by computing network centrality parameters (Scardoni et al. 2009 ) for identifying proteins with a relevant biological and topological signi fi cance (Fig. 9.4 ) . However, some limitations concerning this kind of approaches could be represented by measurements that cover only a small fraction of the network or by organisms with a limited dataset of cataloged protein sequences and interactions. To date, in order to visualize and analyze biological networks, a wide set of bioinformatic tools are available (Suderman and Hallett 2007 ) and include well-known examples, such as Cytoscape (Shannon et al. 2003 ) , VisANT (Hu et al. 2005 ) , Pathway Studio (Nikitin et al. 2003 ) , PATIKA (Demir et al. 2002 ) , Osprey (Breitkreutz et al. 2003 ) , and ProViz (Iragne et al. 2005 ) . Among these, Cytoscape is a Java application whose source code is released under the Lesser General Public License (LGPL). It is probably the most famous open-source software platform for visualizing network datasets and biological pathways and for integrating them with annotations or gene and protein expression pro fi les. Its core distribution provides a basic set of features. However, additional features are available as plugins, thanks to a big community of developers which uses the Cytoscape open API based on Java technology. Most of the plugins are freely available and concern tasks like the importing and the visualizing of networks from various data formats, the generating of networks from literature searches, and the analysis or the fi ltering of them by selecting subsets of nodes and/or interactions in relation with topological parameters, GO annotation, or expression levels. In particular, for analyzing large set of proteomics data, we suggest some plugins, such as: CentiScape (Scardoni et al. -2009 ) that computes speci fi c centrality parameters describing the network topology MCODE (Bader and Hogue -2003 ) that fi nds clusters or highly interconnected regions BiNGO (Maere et al. -2005 ) that determines the Gene Ontology (GO) categories statistically overrepresented in a set of genes or a subgraph of a biological network BioNetBuilder (Avila-Campillo et al. - 2007 ) that offers a user-friendly interface to create biological networks integrated from several databases such as BIND (Alfarano et al. 2005 ) , BioGRID (Stark et al. 2006 ) , DIP (Xenarios et al. 2000 ) , HPRD (Mishra et al. 2006 ) , KEGG , IntAct (Kerrien et al. 2007 ) , MINT (Zanzoni et al. 2002 ) , MPPI (Pagel et al. 2005 ) , and Prolinks (Bowers et al. 2004 ) as well as interolog networks derived from these sources for all species represented in NCBI HomoloGene Fig. 9 .4 By means of Cytoscape software and its plugins, proteins and biomarkers identi fi ed by MudPIT are integrated in protein network for identifying pathways or subnetworks that underline the emergence of speci fi c biological states. In addition, networks identi fi ed by experimental data may be analyzed by plugins, such as CentiScape, for calculating centrality parameters that indicate nodes with relevant biological and topological signi fi cance Other important repositories for protein-protein interaction are STRING (von Mering et al. 2007 ) , Reactome (Joshi-Tope et al. 2005 ) , Pathway Commons (Cerami et al. 2011 ) , and WikiPathways (Pico et al. 2008 ) . However, an exhaustive overview of existing databases is available through the Pathguide website ( http://www. pathguide.org/ ), a useful web resource where about 300 biological pathways and interaction database are described. In the last few years, developments in MS instrumentation have increased both the number of identi fi ed proteins, reaching hundreds to thousands in a single experiment, and the con fi dence of such identi fi cations. Thanks to this relevant amount of data, researchers are characterizing the discovery processes by integrating large set of experimental data into models used to generate hypothesis for testing. For this purpose, systems biology approaches provide a powerful strategy for linking biomarker expression with biological processes that can be segmented and linked to disease presentation. Mass spectrometry-based proteomics is emerging also as a powerful approach suitable to face clinical questions. Even if it is an area of still unrealized potential, clinical proteomics offers the promise of diagnosis, prognosis, and therapeutic follow-up of human diseases. However, given the current status of measurement reproducibility and lack of standardization, further comparative investigations are of great importance. As widely emerged by this chapter, both for basic or clinical research, bioinformatics and statistical tools have a primary importance to support the discovery processes at various levels of sophistication, or for improving the performances of the technologies themselves. In particular, the relevant amount of data produced by the high-throughput proteomics technologies require powerful informatics supports for their organization and interpretation. In this context, several topics concerning data storage, their processing, their visualization, and their interpretation have been faced. However, the need of standards is considered fundamental, and some projects for sharing experimental data between research groups have been launched (e.g., MIAPE, CDISC, and HL7). These should increase meta-analysis, by using raw data from different centers, for helping the development that was grossly underestimated in the initial studies. In addition, as a proteomics community, we believe proteomics methodologies mature for tackling future challenges in clinical proteomics. However, the production of valuable data should rise in step with cooperation with medically focused groups. Overlays -omics empirical data onto metabolic pathways ProteoWizard Set of libraries and tools to perform proteomics data analysis Kessner et al. ( 2008 ) ProteoConnections Web-based set of tools using for analyzing proteomic data A Java Web Start framework that organizes work fl ows for -omics data Kallio et al. ( 2011 ) Multiplierz A scriptable framework that access to manufacturer data fi les Parikh et al. ( 2009 ) Proteomatic A framework that permits to create concatenate scripts in pipeline Specht et al. ( 2011 ) Software to perform statistical analysis on proteomics data Polpitiya et al. ( 2008 ) As for labeling approaches, the stable isotopes may be introduced in the peptide using different methods based on the metabolic, chemical, or enzymatic incorporation (Ong and Mann 2005 ) . Metabolic labeling was described for marking protein of yeast by means of 15 N-enriched cell culture medium (Oda et al. 1999 ) . Since the number of labeled nitrogen atoms may vary from peptide to peptide, stable isotope labeling by amino acids in cell culture (SILAC) approach (Ong et al. 2002 ) was then introduced. In this case, culture medium contains 13 C 6 -Lys and 13 C 6 and 15 N 4 -Arg, ensuring at least one labeled amino acid of tryptic cleavage products. In addition, samples treated with different isotopes may be combined prior to sample preparation minimizing the potential errors introduced by their handling. However, a low cellular growth in adapted media may represent a potential drawback. Methods which allow labeling by chemical or enzymatic incorporation overcome some limitations associated with metabolic labeling. They include isotope-coded af fi nity tags (ICAT), where free cysteine residues are tagged by a reagent containing eight or zero deuterium atoms (Gygi et al. 1999 ) . Tags are linked to the biotin which may be exploited for enriching the labeled peptides using af fi nity puri fi cation prior to MS analysis. Although this strategy reduces the complexity of the peptide mixture, proteins that do not contain cysteine are excluded from the analysis. For this reason, other approaches use reactive residues that occur more frequently in proteins. At this class belong the isobaric tags for relative and absolute quantitation (iTRAQ) (Ross et al. 2004 ) , the tandem mass tags (TMT) (Thompson et al. 1999 ) , and the isotope-coded protein label (ICPL) . In particular, iTRAQ approach is widely used and it is based on the covalent labeling of the N-terminus and side chain amines of peptides. Multiplexing tagging allows the analysis of up to 8 samples per experiment (Choe et al. 2007 ) . In fact, samples differently tagged are pooled and usually fractionated by LC and analyzed by MS/MS. However, problem of co-elution of peptides with similar mass could interfere with the quanti fi cation. Finally, as for enzymatic tagging of peptides, recently trypsin-catalyzed 18 O labeling has grown in popularity due to its simplicity, its cost, and its ability to universally label peptides. Both C-terminal carboxyl group atoms of tryptic peptides can be enzymatically exchanged with 18 O providing a labeled peptide with a 4-Da mass shift from the 16 O-labeled sample (Qian et al. 2011 ) . A direct correlation between the SEQUEST-based score value and the relative abundance of the identi fi ed proteins has been previously demonstrated Regonesi et al. 2006 ) . Based on this fi nding, protein pro fi les of healthy and diseased samples are semiquantitatively compared using a label-free proteomic approach based on DAve (differential average) and DCI (differential con fi dence index) algorithms of MAProMA software . In particular, DAve, which evaluates changes in protein expression, is de fi ned as while DCI, which describes the con fi dence of differential expression, is de fi ned as where X and Y represent the SEQUEST-based score or SpC values of a given protein in two compared samples. Conventionally, signs (+/−) of DAve and DCI indicate if proteins are up-regulated in the fi rst or in the second sample, respectively. A value of DAve >0.4 (or £ −0.4) corresponds to SCORE ratio ³ 1.5. Coupled to a threshold value ³ 400 (or £ −400) for DCI, it allows, with a good reliability, to identify differentially expressed proteins. However, DAve and DCI threshold values may be decreased when calculated, considering mean SCORE values derived from replicate analyses (DAve ³ 0.2 or < −0.2 and DCI ³ 200 and £ −200). On the contrary, when a single analysis per sample/condition is available, a better reliability of the differentially expressed proteins may be assured increasing the threshold values (DAve ³ 0.8 or < −0.8 and DCI ³ 800 and £ −800). - Urinemia SVM support virtual machine, ANN arti fi cial neural network, PCA principal component analysis, DA discriminant analysis, RF random forest, PLS partial least square A confusion matrix presents information about actual and predicted classi fi cations made by a classi fi er. It assesses the classi fi cation performance of the classi fi er. TP, TN, FP, and FN indicate the number of true-positive, true-negative, falsepositive, and false-negative samples, respectively. A false positive is when the outcome is incorrectly classi fi ed as positive. A false negative is when the outcome is incorrectly classi fi ed as negative. True positives and true negatives represent correct classi fi cations. In particular: Biomarkers in the age of omics: time for a systems biology approach The biomolecular interaction network database and related tools 2005 update Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA) Pretreatment of mass spectral pro fi les: application to proteomic data ATP) channel-dependent metaboproteome decoded: systems approaches to heart failure prediction, diagnosis, and therapy BioNetBuilder: automatic integration of biological networks An automated method for fi nding molecular complexes in large protein interaction networks Network biology: understanding the cell's functional organization Machine learning methods for predictive proteomics Evaluation of a cleavable stable isotope labeled synthetic peptide for absolute protein quanti fi cation using LC-MS/MS Systems biology as a foundation for genome-scale synthetic biology MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-in fl ammatory effects Prolinks: a database of protein functional linkages derived from coevolution The APEX quantitative proteomics tool: generating protein quantitation estimates from LC-MS/MS proteomics results Reliable typing of systemic amyloidoses through proteomic analysis of subcutaneous adipose tissue Random forests Osprey: a network visualization system ProtQuant: a tool for the label-free quanti fi cation of MudPIT proteomics data Corra: computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics PatternLab for proteomics: a tool for differential shotgun proteomics Pathway commons, a web resource for biological pathway data TANDEM: matching proteins with tandem mass spectra Open source system for analyzing, validating, and storing protein identi fi cation data The use of proteotypic peptide libraries for protein identi fi cation An introduction to support vector machines and other kernel-based learning methods Technical, bioinformatical and statistical aspects of liquid chromatography-mass spectrometry (LC-MS) and capillary electrophoresis-mass spectrometry (CE-MS) based clinical proteomics: a critical assessment PATIKA: an integrated visual environment for collaborative construction and analysis of cellular pathways The PeptideAtlas project A guided tour of the transproteomic pipeline Bioinformatics tools for mass spectrometry-based proteomics analysis Options and considerations when selecting a quantitative proteomics strategy P6-T Tranche: secure decentralized data storage for the proteomics community A proteomic view of the Plasmodium falciparum life cycle Prediction of high-responding peptides for targeted protein assays by mass spectrometry Changes in the protein expression of yeast as a function of carbon source Absolute quanti fi cation of proteins and phosphoproteins from cell lysates by tandem MS Applying mass spectrometry-based proteomics to genetics, genomics and network biology Feature extraction: foundations and applications The Proteomics Identi fi cations Database (PRIDE) and the ProteomExchange Consortium: making proteomics data accessible ProteomeCommons.org collaborative annotation and project management resource integrated with the Tranche repository VisANT: data-integrating visual framework for biological networks and modules ProViz: protein interaction visualization and exploration Exponentially modi fi ed protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein Pathway analysis of dilated cardiomyopathy using global proteomic pro fi ling and enrichment maps Visual integration of quantitative proteomic data, pathways, and protein interactions Reactome: a knowledgebase of biological pathways The KEGG resource for deciphering the genome IntAct-open source resource for molecular interaction data Metabolic network modeling and simulation for drug targeting and discovery Protein quantitation using isotope-assisted mass spectrometry Scoring proteomes with proteotypic peptide probes Selected reaction monitoring for quantitative proteomics: a tutorial Feature selection and nearest centroid classi fi cation for protein mass spectrometry Network-assisted protein identi fi cation and data interpretation in shotgun proteomics A model for random sampling and estimation of relative protein abundance in shotgun proteomics Absolute quanti fi cation of speci fi c proteins in complex mixtures using visible isotope-coded af fi nity tags BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks Computational prediction of proteotypic peptides for quantitative proteomics ProteinQuant suite: a bundle of automated software tools for label-free quantitative proteomics PRIDE: the proteomics identi fi cations database SBEAMS-microarray: database software supporting genomic expression analyses for systems biology A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli Multidimensional protein identi fi cation technology for clinical proteomic analysis Identi fi cation of proteins released by pancreatic cancer cells by multidimensional protein identi fi cation technology: a strategy for identi fi cation of novel cancer markers Comparative evaluation of current peptide production platforms used in absolute quanti fi cation in proteomics Human protein reference database-2006 update MSQuant, an open source platform for mass spectrometry-based quantitative proteomics Interpretation of shotgun proteomic data the protein inference problem Pathway studio-the analysis and navigation of molecular networks Mass spectrometry in high-throughput proteomics: ready for the big time Implementing data standards: a report on the HUPOPSI workshop The MIPS mammalian protein-protein interaction database Mass spectrometry in clinical proteomics -from the present to the future A quantitative analysis software tool for mass spectrometrybased proteomics Linking the proteins --elucidation of proteome-scale networks using mass spectrometry WikiPathways: pathway editing for the people MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular pro fi le data Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach Classi fi cation algorithms for phenotype prediction in genomics and proteomics From proteomics toward systems biology: integration of different types of proteomics data into network models A direct adaptive method for faster backpropagation learning: the RPROP algorithm A comparison of methods for classifying clinical samples based on proteomics data: a case study for statistical and machine learning approaches Prediction of peptides observable by mass spectrometry applied at the experimental set level Analyzing biological network parameters with CentiScaPe Cytoscape: a software environment for integrated models of biomolecular interaction networks Application of ion trap technology to liquid chromatography/mass spectrometry quantitation of large peptides Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study Quantitative mass spectrometry-based techniques for clinical use: biomarker identi fi cation and quanti fi cation Identi fi cation of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identi fi cation technology (MudPIT) BioGRID: a general repository for interaction datasets Tools for visually exploring biological networks A computational approach toward label-free protein quanti fi cation using predicted peptide detectability The nature of statistical learning theory STRING 7-recent developments in the integration and prediction of protein interactions Quanti fi cation of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards Support vector machines for improved peptide identi fi cation from tandem mass spectrometry database search Systems biology approaches and pathway tools for investigating cardiovascular disease DIP: the database of interacting proteins MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-speci fi c peptides Proteomics by mass spectrometry: approaches, advances, and applications Multiple peak alignment in sequential data analysis: a scale-space-based approach MINT: a Molecular INTeraction database Detecting differential and correlated protein expression in label-free shotgun proteomics Mass spectrometry-based label-free quantitative proteomics Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae Serum biomarker panels for the diagnosis of gastric adenocarcinoma Identi fi cation of Acinetobacter species: is Bruker biotyper MALDI-TOF mass spectrometry a good alternative to molecular techniques? The feasibility of MS and advanced data processing for monitoring Schistosoma mansoni infection MudPIT analysis of released proteins in Pseudomonas aeruginosa laboratory and clinical strains in relation to pro-in fl ammatory effects Corra: computational framework and tools for LC-MS discovery and targeted mass spectrometry-based proteomics ATAQS: a computational software tool for high throughput transition optimization and validation for selected reaction monitoring mass spectrometry Serum albumin-bound proteomic signature for early detection and staging of hepatocarcinoma: sample variability and data classi fi cation 8-plex quantitation of changes in cerebrospinal fl uid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease ProteoConnections: a bioinformatics platform to facilitate proteome and phosphoproteome analyses Urinary proteomics to support diagnosis of stroke Trans-proteomic pipeline supports and improves analysis of electron transfer dissociation data sets Novel molecular tumour classi fi cation using MALDI-mass spectrometry imaging of tissue micro-array MS Data Miner: a web-based software tool to analyze, compare and share mass spectrometry protein identi fi cations Detection and identi fi cation of potential biomarkers of breast cancer Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis Proteomics analysis of plasma for early diagnosis of endometriosis Outcome prediction in pneumonia induced ALI/ARDS by clinical features and peptide patterns of BALF determined by mass spectrometry Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-fl ight mass spectrometry Quantitative analysis of complex protein mixtures using isotope-coded af fi nity tags Nonnegative principal component analysis for mass spectral serum pro fi les and biomarker discovery Cerebrospinal fl uid proteomic patterns discriminate Parkinson's disease and multiple system atrophy Plasma biomarkers distinguish non-small cell lung cancer from asthma and differ in men and women Chipster: user-friendly analysis software for microarray and other highthroughput data The KEGG resource for deciphering the genome ProteoWizard: open source software for rapid proteomics tools development Metabolic network modeling and simulation for drug targeting and discovery Proteomic pattern analysis discriminates among multiple sclerosis-related disorders Matrix-assisted laser desorption/ionization mass spectrometric investigation of pollen and their classi fi cation by multivariate statistics Evaluation of endometrial biomarkers for semi-invasive diagnosis of endometriosis Characterization of Yersinia using MALDI-TOF mass spectrometry and chemometrics Imaging mass spectrometry -a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas Imaging mass spectrometry provides fi ngerprints for distinguishing hepatocellular carcinoma from cirrhosis Mass spectrometry protein expression pro fi les in colorectal cancer tissue associated with clinico-pathological features of disease A classi fi cation method based on principal components of SELDI spectra to diagnose of lung adenocarcinoma Serum protein pro fi ling of smearpositive and smear-negative pulmonary tuberculosis using SELDI-TOF mass spectrometry Proteomic pro fi ling of mucosal and submucosal colonic tissues yields protein signatures that differentiate the in fl ammatory colitides A proteomic approach to the analysis of RNA degradosome composition in Escherichia coli Identi fi cation of proteins released by pancreatic cancer cells by multidimensional protein identi fi cation technology: a strategy for identi fi cation of novel cancer markers Tumor classi fi cation of six common cancer types based on proteomic pro fi ling by MALDI imaging Accurate quantitation of protein expression and site-speci fi c phosphorylation Mass spectrometry-based proteomics turns quantitative Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics Multiplierz: an extensible API based desktop environment for proteomics data analysis A mass spectrometric multicenter study supports classi fi cation of preeclampsia as heterogeneous disorder DAnTE: a statistical tool for quantitative analysis of -omics data Trypsin-catalyzed oxygen-18 labeling for quantitative proteomics Analysis of the Escherichia coli RNA degradosome composition by a proteomic approach Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents A novel strategy for quantitative proteomics using isotopecoded protein labels Placental stem cells pre-treated with a hyaluronan mixed ester of butyric and retinoic acid to cure infarcted pig hearts: a multimodal study Identi fi cation of serum protein biomarkers in biliary atresia by mass spectrometry and ELISA Proteomics to go: proteomatic enables the userfriendly creation of versatile MS/MS data evaluation work fl ows Proteomic pro fi ling of uremia in serum using magnetic bead-based sample fractionation and MALDI-TOF MS Ovarian cancer classi fi cation based on dimensionality reduction for SELDI-TOF data The physiological structure of human C-reactive protein and its complex with phosphocholine Early detection of ovarian cancer in samples pre-diagnosis using CA125 and MALDI-MS peaks CPFP: a central proteomics facilities pipeline Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS Proteomic patterns analysis with multivariate calculations as a promising tool for prompt differentiation of early stage lung tissue with cancer and unchanged tissue material Identi fi cation biomarkers of eutopic endometrium in endometriosis using arti fi cial neural networks and protein fi ngerprinting FluTyper-an algorithm for automated typing and subtyping of the in fl uenza virus from high resolution mass spectral data Application of serum protein fi ngerprint in diagnosis of pancreatic cancer. Zhejiang Da Xue Xue Bao Yi Xue Ban Acknowledgments This study was supported by the Italian Ministry of Economy and Finance to the CNR for the Project "FaReBio di Qualita," by Italian Ministry of University and Research for the Project FAR and by Fondazione Cariplo (2010-0653). Dr. Mauri has a notable experience in the development and application of several technologies (HPLC, capillary electrophoresis, mass spectrometry) for the identi fi cation and quanti fi cation of several biomolecules in complex matrices. He has been involved in the study of the bioavailability of several drugs in humans and animals.He has set up a proteomics laboratory based on both traditional proteomic technologies (2D gel and off-line identi fi cation LC-MS/MS) and innovative approaches. In particular, he is among the fi rst Italian researchers to use the MudPIT methodology (2DC-MS/MS) and a parallel computing system for proteomics. The latter instrumentation allows for the proteomic pro fi ling of biological samples, without limitations, according to protein molecular weight, pI, or hydrophobicity, and guarantees high productivity. Using this methodology, secreted proteins from tumor ( FASEB 2005) and immune system cells have been characterized. Furthermore, direct analysis of biological samples ( JMS 2007) , enzymatic complexes ( Biochimie 2006), development of novel methodological approaches for studying switch-redox proteins ( JBC 2005 , JMB 2006 , and structural and functional characterization of proteins ( Biol. Chem. 2004 , FEBS 2006 have been performed.In addition, he has developed analytical methods for qualiquantitative characterization of natural bioactive compounds (such as polyphenols and terpenes from Ginkgo biloba and other medicinal plants), and bioavailability studies in human and animals have been performed. He is coauthor of more than 100 scienti fi c publications; he has participated in numerous international congresses and has taught in several metabolomic and proteomic courses.